Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study

Fichiers

13223_2023_Article_805.pdf (859.45 KB)

Date

Authors

Cowan, Juthaporn

Gladiator, André

Citation

Allergy, Asthma & Clinical Immunology. 2023 Jun 23;19(1):54

URI

https://doi.org/10.1186/s13223-023-00805-3
https://doi.org/10.20381/ruor-29301
http://hdl.handle.net/10393/45095

Collections

Publications par les auteurs d'uOttawa publiés par BioMed Central // uOttawa authored publications from BioMed Central

Notice complète